FWM
RXST icon

Focused Wealth Management’s RxSight RXST Stock Holding History

Focused Wealth Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-60
Closed -$2.42K – 806
2023
Q4 		$2.42K Hold
60
– – ﹤0.01% 753
2023
Q3 		$1.67K Hold
60
– – ﹤0.01% 795
2023
Q2 		$1.73K Hold
60
– – ﹤0.01% 820
2023
Q1 		$1K Buy
+60
New +$847 ﹤0.01% 868

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Focused Wealth Management's RXST Position: Q1 2024 in Review

Focused Wealth Management sold out of RxSight (RXST) in Q1 2024, closing a stake of 60 shares — an estimated $2.42K sold.

Focused Wealth Management first reported a position in RXST in Q1 2023 and held it in 4 quarters. The position peaked at $2.42K in Q4 2023. 197 funds tracked by Wall St. Rank hold RXST as of Q1 2024.

  • Focused Wealth Management reported no remaining RxSight position as of Q1 2024 after selling out during the quarter.
  • Focused Wealth Management sold 60 RxSight shares in Q1 2024, an estimated $2.42K.
  • Focused Wealth Management first reported a position in RxSight in Q1 2023 and held it in 4 quarters.
  • Focused Wealth Management's RxSight position peaked at $2.42K in Q4 2023.
  • 197 funds tracked by Wall St. Rank held RxSight as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.